{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:38:43Z","timestamp":1790033923326,"version":"4.0.1"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01820","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T04:55:41Z","timestamp":1599713741000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis"],"prefix":"10.3389","volume":"11","author":[{"given":"Sara","family":"Caputo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Grioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara S.","family":"Brambillasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Monno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Brevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Freschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio S.","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela R.","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Baccega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Doglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Jachetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41568-018-0006-7","article-title":"A history of exploring cancer in context","volume":"18","author":"Maman","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1158\/2159-8290.CD-14-0788","article-title":"How does multistep tumorigenesis really proceed?","volume":"5","author":"Chaffer","year":"2015","journal-title":"Cancer Discov"},{"key":"B4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/S1462399408000719","article-title":"Galectins: structure, function and therapeutic potential","volume":"10","author":"Yang","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","article-title":"Galectin 3 as a guardian of the tumor microenvironment","volume":"1863","author":"Ruvolo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrc1527","article-title":"Galectins as modulators of tumour progression","volume":"5","author":"Liu","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00798.x","article-title":"Galectin-3 regulates T-cell functions","volume":"230","author":"Hsu","year":"2009","journal-title":"Immunol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41585-019-0183-5","article-title":"Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities","volume":"16","author":"Martinez-Bosch","year":"2019","journal-title":"Nat Rev Urol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/1097-0045(20000701)44:2<118::AID-PROS4>3.0.CO;2-U","article-title":"Decreased galectin-3 expression in prostate cancer","volume":"44","author":"Pacis","year":"2000","journal-title":"Prostate"},{"key":"B14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/1097-0215(20000720)89:4<361::AID-IJC8>3.0.CO;2-U","article-title":"Alteration of the cytoplasmic\/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression","volume":"89","author":"Van Den Brule","year":"2000","journal-title":"Int J Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/pros.20688","article-title":"Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer","volume":"68","author":"Merseburger","year":"2008","journal-title":"Prostate"},{"key":"B16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00345-012-0925-y","article-title":"Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence","volume":"31","author":"Knapp","year":"2013","journal-title":"World J Urol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1593\/tlo.09118","article-title":"Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer","volume":"2","author":"Ahmed","year":"2009","journal-title":"Transl Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2353\/ajpath.2009.080816","article-title":"Regulation of prostate cancer progression by galectin-3","volume":"174","author":"Wang","year":"2009","journal-title":"Am J Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/jnci\/87.5.348","article-title":"Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin","volume":"87","author":"Pienta","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"B20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.18632\/oncotarget.923","article-title":"Galectin-3: a possible complementary marker to the PSA blood test","volume":"4","author":"Balan","year":"2013","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","first-page":"82266","DOI":"10.18632\/oncotarget.12619","article-title":"Positive associations between galectin-3 and PSA levels in prostate cancer patients: a prospective clinical study-I","volume":"7","author":"Nakajima","year":"2016","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e2337","DOI":"10.1038\/cddis.2016.239","article-title":"Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics","volume":"7","author":"Ilmer","year":"2016","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"68229","DOI":"10.18632\/oncotarget.11920","article-title":"Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain","volume":"7","author":"Kang","year":"2016","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/glycob\/cwv088","article-title":"Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer","volume":"26","author":"Kuo","year":"2016","journal-title":"Glycobiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1111\/jcmm.13860","article-title":"Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma","volume":"22","author":"Huang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/glycob\/cwy001","article-title":"Galectin-3 and cancer stemness","volume":"28","author":"Nangia-Makker","year":"2018","journal-title":"Glycobiology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.5966\/sctm.2013-0041","article-title":"Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors","volume":"2","author":"Mazzoleni","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/0008-5472.CAN-14-2346","article-title":"Tenascin-C protects cancer stem-like cells from immune surveillance by arresting T-cell activation","volume":"75","author":"Jachetti","year":"2015","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","article-title":"Prostate cancer in a transgenic mouse","volume":"92","author":"Greenberg","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/eji.200425531","article-title":"Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization","volume":"35","author":"Degl'innocenti","year":"2005","journal-title":"Eur J Immunol"},{"key":"B34","first-page":"3325","article-title":"Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model","volume":"57","author":"Foster","year":"1997","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ijc.2910210305","article-title":"Isolation of a human prostate carcinoma cell line (DU 145)","volume":"21","author":"Stone","year":"1978","journal-title":"Int J Cancer"},{"key":"B36","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Invest Urol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-09-4253","article-title":"Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors","volume":"70","author":"Hess Michelini","year":"2010","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.4049\/jimmunol.177.4.2131","article-title":"Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responses","volume":"177","author":"Iezzi","year":"2006","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"15074","DOI":"10.1073\/pnas.96.26.15074","article-title":"Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy","volume":"96","author":"Kwon","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1158\/1078-0432.CCR-17-2210","article-title":"Targeting tumor vasculature with TNF leads effector T cells to the tumor and enhances therapeutic efficacy of immune checkpoint blockers in combination with adoptive cell therapy","volume":"24","author":"Elia","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nmeth.1674","article-title":"Site-specific integration and tailoring of cassette design for sustainable gene transfer","volume":"8","author":"Lombardo","year":"2011","journal-title":"Nat Methods"},{"key":"B42","doi-asserted-by":"publisher","first-page":"277ra228","DOI":"10.1126\/scitranslmed.aaa1405","article-title":"Liver-directed lentiviral gene therapy in a dog model of hemophilia B","volume":"7","author":"Cantore","year":"2015","journal-title":"Sci Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1158\/0008-5472.CAN-17-3117","article-title":"Interleukin-30\/IL27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization","volume":"78","author":"Sorrentino","year":"2018","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e24520","DOI":"10.4161\/onci.24520","article-title":"Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses","volume":"2","author":"Jachetti","year":"2013","journal-title":"Oncoimmunology"},{"key":"B45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-030-16624-3_8","article-title":"Crosstalk between prostate cancer stem cells and immune cells: implications for tumor progression and resistance to immunotherapy","volume-title":"Cancer Stem Cell Resistance to Targeted Therapy","author":"Bellone","year":"2019"},{"key":"B46","doi-asserted-by":"publisher","first-page":"667","DOI":"10.18632\/oncoscience.210","article-title":"Immunosuppression via tenascin-C","volume":"2","author":"Bellone","year":"2015","journal-title":"Oncoscience"},{"key":"B47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/sj.cr.7290134","article-title":"Stem cell pluripotency and transcription factor Oct4","volume":"12","author":"Pan","year":"2002","journal-title":"Cell Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1158\/0008-5472.CAN-13-1559","article-title":"Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas","volume":"74","author":"Sangiolo","year":"2014","journal-title":"Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2008.01.011","article-title":"Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes","volume":"28","author":"Demotte","year":"2008","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat Genet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fonc.2014.00138","article-title":"Extracellular galectin-3 in tumor progression and metastasis","volume":"4","author":"Fortuna-Costa","year":"2014","journal-title":"Front Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1158\/0008-5472.CAN-15-1793","article-title":"Galectin-3 cleavage alters bone remodeling: different outcomes in breast and prostate cancer skeletal metastasis","volume":"76","author":"Nakajima","year":"2016","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1158\/0008-5472.CAN-16-2636","article-title":"How the TRAMP model revolutionized the study of prostate cancer progression","volume":"76","author":"Gelman","year":"2016","journal-title":"Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1200\/JCO.2015.65.7270","article-title":"Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer","volume":"34","author":"Halabi","year":"2016","journal-title":"J Clin Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrc3223","article-title":"Unmasking the immune recognition of prostate cancer with CTLA4 blockade","volume":"12","author":"Kwek","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00262-012-1216-6","article-title":"Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy","volume":"61","author":"Rigamonti","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B58","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ccr.2005.01.027","article-title":"Androgen ablation mitigates tolerance to a prostate\/prostate cancer-restricted antigen","volume":"7","author":"Drake","year":"2005","journal-title":"Cancer Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/0008-5472.CAN-07-2429","article-title":"Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells","volume":"68","author":"Degl'innocenti","year":"2008","journal-title":"Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1158\/0008-5472.CAN-08-4102","article-title":"Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model","volume":"69","author":"Wada","year":"2009","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20042028","article-title":"Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers","volume":"201","author":"Bronte","year":"2005","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/1078-0432.CCR-10-2547","article-title":"Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer","volume":"17","author":"Rigamonti","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s002400050164","article-title":"Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer","volume":"27","author":"Ellerhorst","year":"1999","journal-title":"Urol Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature09677","article-title":"SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression","volume":"470","author":"Ding","year":"2011","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.juro.2007.08.133","article-title":"The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy","volume":"179","author":"Makarov","year":"2008","journal-title":"J Urol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"14496","DOI":"10.1073\/pnas.0903497106","article-title":"Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B67","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation","volume":"409","author":"Demetriou","year":"2001","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1128\/MCB.26.8.3181-3193.2006","article-title":"Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells","volume":"26","author":"Lagana","year":"2006","journal-title":"Mol Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1046\/j.1471-4159.1995.64062465.x","article-title":"Galectin-3, a beta-galactoside-binding animal lectin, binds to neural recognition molecules","volume":"64","author":"Probstmeier","year":"1995","journal-title":"J Neurochem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0344-0338(00)80122-3","article-title":"Adhesive and invasive features in gliomas","volume":"196","author":"Tews","year":"2000","journal-title":"Pathol Res Pract"},{"key":"B71","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.1038\/sj.onc.1207997","article-title":"Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3","volume":"23","author":"Califice","year":"2004","journal-title":"Oncogene"},{"key":"B72","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.immuni.2012.03.004","article-title":"Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer","volume":"36","author":"Rabinovich","year":"2012","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1074\/jbc.M808925200","article-title":"Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation","volume":"284","author":"Stowell","year":"2009","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6852","DOI":"10.1074\/jbc.M107668200","article-title":"Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest","volume":"277","author":"Yoshii","year":"2002","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/ijms19010210","article-title":"Galectin targeted therapy in oncology: current knowledge and perspectives","volume":"19","author":"Wdowiak","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1182\/blood-2009-10-251660","article-title":"GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death","volume":"115","author":"Streetly","year":"2010","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1534735410369672","article-title":"PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and- independent prostate cancer cells","volume":"9","author":"Yan","year":"2010","journal-title":"Integr Cancer Ther"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1002\/cam4.2334","article-title":"Pectasol-C modified citrus pectin targets galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids","volume":"8","author":"Hossein","year":"2019","journal-title":"Cancer Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.1158\/0008-5472.CAN-10-0761","article-title":"A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice","volume":"70","author":"Demotte","year":"2010","journal-title":"Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1073\/pnas.1202653110","article-title":"Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis","volume":"110","author":"Guha","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e1434467","DOI":"10.1080\/2162402X.2018.1434467","article-title":"The role of galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment","volume":"7","author":"Farhad","year":"2018","journal-title":"Oncoimmunology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3389\/fimmu.2018.01786","article-title":"Immune checkpoint-mediated interactions between cancer and immune cells in prostate adenocarcinoma and melanoma","volume":"9","author":"Elia","year":"2018","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T07:20:36Z","timestamp":1599808836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2020.01820"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01820","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"article-number":"1820"}}